Finance

Beta
Ask
Lists
ARMP:NYSEAMERICAN
Armata Pharmaceuticals Inc
$7.06
+3.98%
(+0.27) 1D
Jun 17, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARMP...
Open
$6.91
High
$7.15
Low
$6.76
Mkt. cap
259.18M
Avg. vol.
70.46K
Volume
33.69K
52-wk high
$16.34
52-wk low
$1.75
EPS
-$7.76
Beta
1.21
Shares outstanding
36.71M
No. of employees
61
Open
$6.91
High
$7.15
Low
$6.76
Mkt. cap
259.18M
Avg. vol.
70.46K
Volume
33.69K
52-wk high
$16.34
52-wk low
$1.75
EPS
-$7.76
Beta
1.21
Shares outstanding
36.71M
No. of employees
61
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to ARMP in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ARMP in the last 3 months.
Highest
Current $7.06
$20.00 (+183.29%)
Average
$17.50 (+147.88%)
Lowest
$15.00 (+112.46%)
News stories
From sources across the web
About Armata Pharmaceuticals Inc
CEO-
Employees61
Founded1989
HeadquartersLos Angeles, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.17M
1.16M
1.08M
789.00K
Cost of goods sold
167.00K
5.82M
-1.93M
-
Cost of revenue
167.00K
5.82M
-1.93M
-
Research and development expenses
6.23M
-
-
6.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.62M
3.11M
11.43M
3.46M
Operating expense
8.85M
3.11M
11.43M
9.57M
Total operating expenses
9.01M
8.94M
9.50M
9.57M
Operating income
-6.84M
-7.78M
-8.41M
-8.78M
Other non operating income
-
-
-
-
EBT including unusual items
-16.30M
-26.68M
-124.30M
-115.35M
EBT excluding unusual items
-10.54M
-12.03M
-13.11M
-14.28M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.30M
-26.68M
-124.30M
-115.35M
Net profit margin
-751.27%
-2,301.55%
-11,456.04%
-14,619.26%
Earnings per share
-0.29
-0.33
-0.36
-
Interest and investment income
108.00K
90.00K
131.00K
60.00K
Interest expense
-3.81M
-4.35M
-4.83M
-5.56M
Net interest expenses
-3.70M
-4.26M
-4.70M
-5.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.48M
-7.41M
-7.99M
-8.33M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more